Moderna Launches Another mRNA-Based Injection Targeting The Common Cold RSV
The genie of mRNA gene therapy injections is out of the bottle. Moderna's new shot targets the common cold RSV, an extremely low-risk virus, and the FDA has granted fast-track designation for rapid approval.